France's Sanofi has agreed to buy U.S.-based Blueprint Medicines Corporation for up to $9.5 billion to boost its position in ...

PARIS (Reuters) -French pharma group Sanofi has agreed to buy US-based Blueprint Medicines Corporation, a biopharmaceutical ...

Good morning. Morgan Stanley sees the US dollar weakening another 9% in the year ahead. Ukrainian drones hit as far as ...

U.S. liquefied natural gas output fell in May due to plant outages and maintenance at the country's largest export facility, ...

China has blasted the U.S. for issuing AI chip export control guidelines, stopping the sale of chip design software to China, ...

Shares rose early Tuesday in Asia after US stock indexes drifted closer to records, while oil prices extended gains.

Sanofi will buy the US maker of the world’s only approved treatment for a debilitating rare blood disorder for up to $9.5bn, as it seeks to boost its immunology medicine pipeline.

British investment firm Rosebank Industries said on Monday it has restarted talks to buy U.S.-based Electrical Components International, which makes wire harnesses, for under $1.9 billion.

US President Donald Trump has set a deadline of July 9 for countries to avoid sweeping tariffs. Lutnick said that he was a ...

New research suggests that removing fluoride from public water would increase dental care costs and tooth decay for children ...

Donald Trump’s administration has begun a process to open swaths of Alaska’s wilderness to oil drillers by scrapping Joe ...

Two U.S. senators are warning that Russian President Vladimir Putin is stalling on peace while preparing a fresh military ...